News

arGentis anticipates the confirmation process by the European Commission should be finalized in early 2009. Once confirmed, arGentis subsidiary, arGentis Autoimmune Europe, will gain access to incentives including

The Culex automated in vivo sampling system is designed to collect pharmacokinetic and pharmacodynamic (PK/PD) data during the course of drug metabolism experiments. The Culex systems can collect

Under the terms of the agreement, BioMarin will receive a co-exclusive license to develop and commercialize Riquent and La Jolla could receive up to $289 million in cash

The Phase I clinical trial is an open label, dose determination study which will be conducted in the US with approximately 24 hemodialysis patients in two treatment cohorts.

Robert Thomas, chairman of board of directors of Concentric Medical, said: “The positive developments at Concentric over the last several months made the opportunity to participate in this

Prior to joining Bristol-Myers Squibb, Dr Feldman served as professor and head of the division of neurology at University of British Columbia and Vancouver Coastal Health, Vancouver, Canada.

Applications similar to these patents are pending worldwide, and several additional applications that address other compositions and uses have been filed in the US and other territories. These

In July of 2008, Osiris announced the sale of the Osteocel business to NuVasive for an initial payment of $35 million, followed by up to $50 million in

Dr Barer currently serves as chairman and CEO of Celgene. Dr Barer has received a PhD in organic chemistry from Rutgers University. Separately, Amicus announced that Gregory Weinhoff